The American Journal of Medicine
Volume 122, Issue 5 , Page e17 , May 2009

The Reply

References 

  1. Mortensen EM, Restrepo MI, Anzueto A, et al. The effect of prior statin use on 30-day mortality for patients hospitalized with community acquired pneumonia. Respir Res. 2005;25;:6;82
  2. Fessler MB, Young SK, Jeyaseelan S, et al. A role for hydroxy-methylglutaryl coenzyme A reductase in pulmonary inflammation and host defense. Am J Respir Crit Care Med. 2005;171:606–615
  3. Chalmers JD, Singanayagam A, Murray MP, Hill AT. Prior statin use is associated with improved outcomes in community-acquired pneumonia. Am J Med. 2008;121:1002–1007e1
  4. Majumdar SR, McAllister FA, Eurich DT, et al. Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study. BMJ. 2006;333:999
  5. 1 Eurich DT, Marrie TJ, Johnstone J, Majumdar SR. Mortality reduction with influenza vaccine in patients with pneumonia outside “flu” season: pleiotropic benefits or residual confounding?. Am J Respir Crit Care Med. 2008;178:527–533Epub 2008 Jun 12
  6. Jackson ML, Nelson JC, Weiss NS, et al. Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case control study. Lancet. 2008;372:352–354

PII: S0002-9343(09)00052-7

doi: 10.1016/j.amjmed.2008.12.014

The American Journal of Medicine
Volume 122, Issue 5 , Page e17 , May 2009

Article Tools